Application Sponsors
ANDA 213875 | AUROBINDO PHARMA LTD | |
Marketing Status
Application Products
001 | CAPSULE;ORAL | 25MG | 0 | DICLOFENAC POTASSIUM | DICLOFENAC POTASSIUM |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2021-10-19 | STANDARD |
Submissions Property Types
TE Codes
CDER Filings
AUROBINDO PHARMA LTD
cder:Array
(
[0] => Array
(
[ApplNo] => 213875
[companyName] => AUROBINDO PHARMA LTD
[docInserts] => ["",""]
[products] => [{"drugName":"DICLOFENAC POTASSIUM","activeIngredients":"DICLOFENAC POTASSIUM","strength":"25MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"10\/19\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2021-10-19
)
)